drugset / Trial / NCT02613195

Clinical Trial of Hydrogen-Rich Celsior Solution Applied in Aging DBD Liver/Kidney Transplantation

NCT02613195 ↗

Phase 3 Unknown 20 enrolled RenJi Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to investigate whether hydrogen-rich Celsior solution improve the quality of aging grafts in liver/kidney transplantation.

Timeline

Start
2016-01
Primary completion
2017-02
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrogen-Rich Celsior Solution Unknown — Other

Indications

No indication recorded.